About us
at.las ATMP is a collaborative network that unites Antwerp’s leading expertise in cell, gene, and tissue therapy, internationally recognized for advances in cancer, autoimmune, and other disease treatments. By linking academia, hospitals, and industry within a strong innovation ecosystem, it fosters collaboration, accelerates research, drives translational development, and reinforces Antwerp’s position as a global center of excellence for advanced therapy medicinal products and enabling technologies.
Our mission is to foster value-based research & innovation to leverage affordable solutions for advanced therapies
BUILD NETWORK
Facilitator of Collaboration
at.las ATMP connects universities, hospitals, biotech companies, and pharmaceutical partners, fostering joint projects, sharing knowledge, and aligning resources to accelerate innovation.
Ecosystem Builder
By encouraging public-private partnerships, connecting start-ups with investors, and supporting clinical collaborations, at.las ATMP helps the growth of a vibrant and sustainable cell, gene and tissue therapy ecosystem in Antwerp.
▪︎ Align strategic partner priorities
▪︎ Local to international networking with stakeholders throughout the value chain
▪︎ Impact-driven matchmaking
FOSTER INNOVATION, VALORISATION & COLLABORATION
Research & Innovation Accelerator
The network supports the development, translation, and commercialization of therapies and enabling technologies, from early research to clinical trials and from proof-of-concept to valuable assets, by providing strategic and regulatory guidance, and project support.
ATMP Spearpoints
Therapeutics
Clinical studies
Enabling technologies
Manufacturing
Logistics
Regulatory-accessibility framework
▪︎ Build on (pre)/clinical expertise & enabling technologies, manufacturing & logistics
regulatory & accessibility framework
▪︎ Identify opportunities for collaboration & funding
▪︎ Support value-driven R&I projects from start-up to execution
SHOWCASE THE EXPERTISE, TECHNOLOGIES & TRAINING HUB
Talent & Expertise Hub
By centralizing access to scientific, clinical, and technical expertise and by developing specialized training programs, at.las ATMP helps attract and train top talent in fast-evolving and growing domain of advanced therapies.
Promoter of Antwerp’s Global Positioning
at.las ATMP strengthens Antwerp’s visibility on the international cell, gene and tissue therapy stage, highlighting the region as a center of excellence for ATMP development and ATMP enabling technologies.
▪︎ Align & communicate assets, initiatives and achievement
▪︎ Develop trainings in the larger learning network
▪︎ Promote Antwerp’s positioning
Team
The Alliance Manager
As the first Alliance manager for the Antwerp Life Sciences subdomain of cell, gene and tissue therapies since 2025, Eva Lion plays a key role in strengthening strategic partnerships by connecting academic, industry and public stakeholders, aligning objectives, and supporting collaborative initiatives to advance innovation. Formerly head of the Tumor Immunology Group at the Laboratory of Experimental Hematology (LEH, University of Antwerp) and clinical research coordinator at the Center for Cell Therapy and Regenerative Medicine (CCRG, Antwerp University Hospital), she lead basic, translational and clinical research in the field of personalized cell vaccination and adoptive cell therapies. Drawing on this background, she brings extensive expertise in bridging research with clinical and technological applications to support collaborative innovation in advanced therapy research.
Eva Lion
Jade Verrept
As co-founder of at.las ATMP and Program Manager at POM Antwerpen, Jade is the driving force behind the growth of the ATMP Innovation Cluster at the Science Park UAntwerp.
Evemie Schutyser
As Senior Valorisation Manager for the Life Sciences at UAntwerp, Evemie is the soundboard for the innovation and partnership priorities.
Nathalie Cools
As co-founder of at.las ATMP, vice-dean Research & Valorisation at UAntwerp’s Faculty of Medicine and Health Sciences, and CEO of anicells, Nathalie fuels the broad value chain from research, education and valorsation perspectives.
Sébastien Anguille
Heading the Hematology clinical and research departments and directing the Center for Cell Therapy and Regenerative Medicine at UZA and UAntwerp, Sébastien brings patient-centered and translation-driven insights to the advanced therapies ecosystem.
Partners
